Nurix Therapeutics Inc

NRIX NASDAQ Santé & Biotech États-Unis US67080M1036
16.16 $
5.24 %

Nurix Therapeutics Inc se concentre sur le développement de médicaments qui modulent les protéines de l'ubiquitine pour traiter le cancer et d'autres maladies chroniques.

Performance & Momentum

6 Months 15.29 %
1 Year 27.91 %
3 Years 50.00 %
5 Years 44.20 %

Similar stocks to Nurix Therapeutics Inc

Anantys Community

Be the first to share your analysis on Nurix Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases